| 000 | 01713 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515030114.0 | ||
| 264 | 0 | _c20060718 | |
| 008 | 200607s 0 0 eng d | ||
| 022 | _a0194-7648 | ||
| 024 | 7 |
_a10.1080/01947640600716457 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRuel, Michael D | |
| 245 | 0 | 0 |
_aUsing race in clinical research to develop tailored medications. Is the FDA encouraging discrimination or eliminating traditional disparities in health care for African Americans? _h[electronic resource] |
| 260 |
_bThe Journal of legal medicine _cJun 2006 |
||
| 300 |
_a225-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Legal Case | ||
| 650 | 0 | 4 |
_aBlack or African American _xgenetics |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aDrug Approval _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 |
_aDrug Industry _xeconomics |
| 650 | 0 | 4 | _aDrugs, Investigational |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydralazine _xtherapeutic use |
| 650 | 0 | 4 |
_aIsosorbide Dinitrate _xtherapeutic use |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 |
_aPharmacogenetics _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aPrejudice |
| 650 | 0 | 4 | _aSocioeconomic Factors |
| 650 | 0 | 4 | _aSupreme Court Decisions |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
| 773 | 0 |
_tThe Journal of legal medicine _gvol. 27 _gno. 2 _gp. 225-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/01947640600716457 _zAvailable from publisher's website |
| 999 |
_c16325839 _d16325839 |
||